GI & Endoscopy

Four must-read articles for gastroenterologists:

Takeda Pharmaceuticals continues to combat its Shire acquisition-related debt by selling off another set of non-core assets to Hypera in Brazil, the company announced March 2.

Children's Hospital of Philadelphia researchers have developed a 3D-imaging method that allows them to view the enteric nervous system, News-Medical.net reports.

The FDA awarded Pavmed's EsoGuard Esophageal DNA Test breakthrough device designation to aid in diagnosing Barrett's esophagus.

Orlando, Fla.-based Digestive and Liver Center of Florida implemented AndorHealth's ThinkAndor, an internal communication and collaboration tool that interprets EHR systems and presents information in a more-easily interpretable format.

Here are five recent updates on Exact Sciences and its product, Cologuard:

Three gastroenterology leaders making headlines:

Takedea will acquire PvP Biologics after the company reports results from its phase 1 proof-of-mechanism study of its treatment for uncontrolled celiac disease.

Consolidation is rippling through healthcare, making its mark across an array of specialties, and gastroenterology is no different, according to an analysis from STAT.

Here are eight updates from gastroenterology companies and practices from the past week: